DNA damage analysis by studying Micro nuclei using cytochalassin B in patients with Down syndrome (2012)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2012 - 2013
Project Lead
Amudha S
Authors
Amudha S, Anne, Sayee Rajangam
Project Status
completed
Project Type
short term project